June 9 (Reuters) - Pfizer ( PFE ) and other drug

companies have met with the Trump administration to discuss

most-favored-nation pricing but no commitments have been made,

Chief Executive Albert Bourla said on Monday at an industry

conference.

The meetings focused on high-level ideas and were not

digging into any substance yet, Bourla said.

President Donald Trump issued an executive order last month

aimed at lowering the prices of branded medicines for U.S.

consumers.

(Reporting by Bhanvi Satija and Mariam Sunny in Bengaluru,

Michael Erman in New York; Editing by Anil D'Silva)